logo-loader

Braveheart Investment says investee company expects to be selling new, specially-coated anti-COVID-19 masks by the end of the year

Published: 07:33 23 Oct 2020 BST

Braveheart Investment Group -
The masks are for use by both healthcare professionals and the public, Braveheart said

Braveheart Investment Group PLC (LON:BRH) has said a new antiviral face mask that can kill coronavirus (COVID-19) will go on sale by the end of the year.

This follows a flurry of activity at Braveheart investee company Pharm2Farm (P2F), which has developed a textile coating incorporating nanoparticles with long-lasting virucidal properties.

It now has testing results from two independent labs that show the mask textile has a ‘kill rate’ of over 90% for up to seven hours, meeting the requirements for ISO 18184 certification.

The International Organization for Standardization (ISO) sets the international benchmark for antiviral activity in fabrics.

P2F has now submitted a patent application to protect the intellectual property around the unique coating.

Practically, an automated mask production line capable of producing 5mln units a month will be in production by the end of December.

Finally, Braveheart’s sale of its 51.72% stake in P2F to Remote Monitored Systems PLC (LON:RMS) is expected to complete on November 5. As a result Braveheart will own 37.12% of RMS.

FTSE 100 fails to break 7,500 point ceiling - Market Report

Good morning from London where the FTSE 100 is up so far and hovering around the 7,450 level. It's been scudding along just below the 7,500 level for most of this week. Looking at some equities in particular, housebuilder Berkeley Group Holdings PLC (LSE:BKG) said this morning that it is...

on 8/9/23